BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 34341212)

  • 1. How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.
    Hehlmann R; Lauseker M
    Leukemia; 2024 Feb; 38(2):465-466. PubMed ID: 38218735
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic spontaneous urticaria as the presenting feature in a paediatric case of chronic myeloid leukaemia.
    Sutton KM; Wiggins M; Zaragoza R; Swamy S
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30846. PubMed ID: 38185755
    [No Abstract]   [Full Text] [Related]  

  • 3. What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia?
    Radivoyevitch T; Gale RP; Kalaycio ME
    Leukemia; 2024 Jan; 38(1):207-209. PubMed ID: 37949937
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrapatient competition of VEXAS syndrome and CML clones.
    Djerbi N; Zimmermann K; Roncador M; Becker MO; Manz MG; Balabanov S
    Blood Adv; 2023 Nov; 7(22):6815-6818. PubMed ID: 37738165
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectives.
    Hewison A; Roman E; Smith A; McCaughan D; Sheridan R; Patmore R; Atkin K; Howell D
    Eur J Oncol Nurs; 2023 Dec; 67():102421. PubMed ID: 37804754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rare Case of Dual Metachronous Primary Malignancies, Chronic Myeloid Leukemia, and Tongue Carcinoma in a Patient With Long-Standing Systemic Lupus Erythematosus: A Case Report and Review of Literature.
    BalajiSubramanian S; Al-Hajri T; Satyapal N; Al-Bulushi M; Al Sheibani SM; Al Kalbani FKM; Al-Saadi M; Al Musalhi MN; Al Wahshi HA
    Cureus; 2024 Mar; 16(3):e56648. PubMed ID: 38646281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematological classification of the chronic myeloid leukaemias.
    Shepherd PC; Ganesan TS; Galton DA
    Baillieres Clin Haematol; 1987 Dec; 1(4):887-906. PubMed ID: 3332855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the leucocyte common antigen (LCA, CD45) isoforms RA and RO in acute haematological malignancies: possible relevance in the definition of new overlap points between normal and leukaemic haemopoiesis.
    Schiavone EM; Lo Pardo C; Di Noto R; Manzo C; Ferrara F; Vacca C; Del Vecchio L
    Br J Haematol; 1995 Dec; 91(4):899-906. PubMed ID: 8547136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
    Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
    Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer in relatives of children with myelodysplastic syndrome, acute and chronic myeloid leukaemia.
    Hasle H; Olsen JH
    Br J Haematol; 1997 Apr; 97(1):127-31. PubMed ID: 9136952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homoharringtonine and omacetaxine for myeloid hematological malignancies.
    Lü S; Wang J
    J Hematol Oncol; 2014 Jan; 7():2. PubMed ID: 24387717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
    Xu F; Taki T; Yang HW; Hanada R; Hongo T; Ohnishi H; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
    Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myeloid leukaemia after chemoradiotherapy for solid malignancies.
    Baysal M; Ulutas G; Gokyer A; Umit E; Atli EI; Kirkizlar O; Gürkan H; Demir AM
    Natl Med J India; 2020; 33(6):347-348. PubMed ID: 34341212
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.